Antithymocyte globulin and transplants for aplastic anemia

about

Antithymocyte globulin and transplants for aplastic anemia

Item

http://www.wikidata.org/entity/Q42348449

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Antithymocyte globulin and transplants for aplastic anemia

@en

Antithymocyte globulin and transplants for aplastic anemia

@nl

type

Item

label

Antithymocyte globulin and transplants for aplastic anemia

@en

Antithymocyte globulin and transplants for aplastic anemia

@nl

prefLabel

Antithymocyte globulin and transplants for aplastic anemia

@en

Antithymocyte globulin and transplants for aplastic anemia

@nl

P1476

Antithymocyte globulin and transplants for aplastic anemia

@en

P2093

Andrea Bacigalupo

http://www.w3.org/2001/XMLSchema#string

P2860

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study

Standard treatment of acquired SAA in adult patients 18-40 years old with an HLA-identical sibling donor.

Effect of antithymocyte globulin source on outcomes of bone marrow transplantation for severe aplastic anemia.

A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells.

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

P304

1137-1138

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3324/HAEMATOL.2017.171538

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28655810

http://www.w3.org/2001/XMLSchema#string

P932

5566012

http://www.w3.org/2001/XMLSchema#string